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Half-octave band OAE power a sister who had undergone stapedectomy. He was taking metformin for the diabete s.
The patient said th at th e diplacusis was very distracting during his daily activities, altho ugh he had been able to overcome th e respons e from his own voice by altering his vocal technique. He had been previously treated with three int ratympanic cor ticosteroids, but he felt that this treatment might have on ly made his symptoms worse. He had also been treated with oral prednisone, betahistin e, diuretics, and liothyron ine without ben efit.
The patient had bro ught with him the results of serial audiometr ic tests th at had showed a fluctu ating lowfrequency hear ing loss in th e right ear, although one of these tests showed th at the right ear was normal. He himself had not noticed any hearing loss. Findings on previou s magnetic reson ance imaging with enhancement had been negative for any abnormality,
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3 0 -+--rn A 57-year-o ld male singer with . A noninsulin-d epend ent (type 2) diabetes mellitu s and primary hyperparathyroidi sm pr esent ed with a complaint of diplac usis in th e right ear of 16 months' duration. Th e diplacusis was accompanied by tinnitus, aura l fulln ess, and hyperacusis in the same ear :
Four months after th e onset of th ese symptoms, th e pat ient had experienced a I-week period of recurrent mild positiona l rotary vertigo. Each episode lasted for app roximately 90 seconds. His family history included o Th e patient described the dip lacusis as a harmonic of a fundamental sound in response to extern al sound and to his own voice. When the diplacusis was mo st severe, he would also hear a third sound, either in response to an external sound or as a spontaneous sound th at was close to th e quality of his tinnitus. o The tinnitus seemed to be triggered by the intake of dairy and salicylate pro duc ts, and it could be controlled to some degree by avoidance of these substances. Ano ther type of "howling" tinnitus arose either spo ntaneously or in association with th e int ake of these products.
o Th e aura l fullne ss was intermittent , although it appeared to be related to the int ake of dairy products and salt.
o Th e hyperacusis had been present since th e onset of the diplacu sis. AUDITORY AND VESTIBU LAR MEDICINE C LINIC and laboratory data had revealed hypercalcemia and an elevated parathyroid hormone level. At the patien t's first visit to the aut hor's office, neurotologic testing with tuning forks revealed diplacusis at 512, 2,048, and 4,096 Hz. The patient said the sound from the 512-and 2,048-Hz tuning forks was louder in the right ear than in the left. He experienced significantly more difficulty performing the sharpened tandem Romberg test with th e right foot forward th an with the left foot forward.
At the second visit, audiometry showe d pure ton es at 45 dB at 250 and 500 Hz, with both ears equal from 1.0 kHz and higher. High-frequency hearing testin g revealed hearing in both ears to 15 kHz . The tinnitus in the right ear could no t be m atched. Th e speechreception th reshold was 20 dB in the right ear and 10 dB in the left. Speech discr imi nat ion in qu iet and in simulated backgrou nd noise 'was normal in ho th ears, altho ugh it was slightly less in th e right. Otoacoustic emissions, both tra nsient evoked and distortion product, were presen t in both ears, more so in the left. Thinsection direct axial computed tomography (CT) of the right temporal bone revealed a large sclerotic plaque from the base at the footplate level to the apex, a moderate to large sclerotic plaque of the anterior oval window, and a moderately thickened spongiotic footpl ate, which the radiologist interpreted as otos clerosis of the right ear. On the left side, CT revealed a small sclerotic plaque at the base of the temporal bon e at the footplate level and some spotty demineralization posterior to the apex.
A 2-hour glucose tolerance test showe d diabetic levels of blood glucose and slightly elevated levels of insulin. Thus, th e patient was placed on a str ict diabetic diet, and th e metformin was conti nued. He was also starte d on risedro nate 30 mg twice weekly along with calcium, vitami n D, and sodium monofluorophosphate to address the otosclerosis.
At follow-up 3 months later, the patient reported that the diplacusis had become a litt le worse , the aural fullness more pervasive, and the hyperacusis worse on the days he took the risedronate. Repeat audiometry showed no significant change in his hearing. He was placed on an alternating regimen of etidronate 400 mg/day for 2 weeks and risedronate 30 mg twice weekly for 4 weeks.
The pat ient returned in ano ther 3 months and repor ted that th e diplacusis was better toward the end of the etidro nate cycle but worse on days when he too k risedronate. The diplacusis had become better in th at 774 • www.entjournal.com fewer pitches were affected. Overall, the tinnitus and the aural fullness were bet ter than they had been at the pr evious visit, although he did feel press ure in the right ear when he did not follow his diet . The hyperacusis was unchanged, and the results of hearing tests were unchanged. The alternating bisphosphonate regimen was changed to etidronate 400 mg/day for 2 weeks and risedronate 30 mg twice weekly for 6 weeks.
Four months later, no change had occurred in the diplacusis; it remained better toward th e en d of the etidronate cycle and worse during the days on risedron ate. On a com parative listenin g test with a dial tone, there was less distortion in th e right ear. Th e tinnitus remai ned contro lled with the elimi nation of salicylates. The aural fullness remain ed pr esent , but the patie nt was able to igno re it. The hyperacusis was less frequen t and less acute. There were no significant changes in the results of hearing tests. The pat ient offered that he foun d th e diabetes diet to be "draconian." The alternating bisphosphonate regimen was changed to etidronate 400 mg/ day for 2 weeks an d risedronate 30 mg twice weekly for 11 weeks.
Six months later, which marked the 16th mo nt h of treatment overall, the pat ient returned (and brou ght with him an ar ticle on monaural diplacusis'). Since his previo us visit, the diplacusis was much imp roved; in fact, it had almos t disapp eared and was no lon ger a distraction. The tinnitu s and aural fullness were the same as they had been at the previou s visit, but th e hyperacusis was almos t gone. The result s of repeat hearing tests rem ain ed th e same with the exception of im proved findings with respect to th e tr ansient evoked otoa coustic em issions (figure) . Compared with the previo us visit, th e patien t's hearin g was slightly better in the right ear at 250 and 500 Hz. This is a case of monaural diplac usis.' Based on the pat ient's respo nse to treatment, the etiology appears to be otosclerosis and type 2 diabetes with elevated insulin levels. The intratympanic cor ticosteroids might have produced a permanent hearing loss as a result of their effect on osteoprotegerin in the inner ear. 3 ,4
